ライフサイエンスコーパス: menstrual cycle

1 bility (probability of conception in a given menstrual cycle).

2 between diets (and low hormone phase of the menstrual cycle).

3 ercising in dry and humid heat, across their menstrual cycle.

4 yclicity of cortical excitability across the menstrual cycle.

5 from women with endometriosis throughout the menstrual cycle.

6 n the kinetic parameters and the week of the menstrual cycle.

7 follicular and (2) mid luteal phases of the menstrual cycle.

8 trually in women along with the variation in menstrual cycle.

9 s shed and regenerated each month during the menstrual cycle.

10 ibution for the chance of conceiving in each menstrual cycle.

11 in the high, but not low E(2), phase of the menstrual cycle.

12 women in the low or high E(2) phases of the menstrual cycle.

13 be encountered in vivo throughout the female menstrual cycle.

14 tissue going through remarkable changes each menstrual cycle.

15 ing mammography during the 1st week of their menstrual cycle.

16 pre-receptive and receptive phase within one menstrual cycle.

17 predominantly in premenopausal women at mid menstrual cycle.

18 formance did not differ according to week of menstrual cycle.

19 impaired in women and can be affected by the menstrual cycle.

20 ferent between sexes but not affected by the menstrual cycle.

21 ive hormones important for regulation of the menstrual cycle.

22 attern, in which seizures fluctuate with the menstrual cycle.

23 ular (EFP) and mid-luteal phase (MLP) of the menstrual cycle.

24 obulin A (IgA) and G (IgG) levels during the menstrual cycle.

25 ogen-dominated follicular phase of the human menstrual cycle.

26 cular (EF) and mid-luteal (ML) phases of the menstrual cycle.

27 tween men and women nonsmokers or across the menstrual cycle.

28 and mid-luteal (days 19-25) phases of their menstrual cycle.

29 -measures, counterbalanced design across the menstrual cycle.

30 ith urine PdG during the luteal phase of the menstrual cycle.

31 and stroma during the secretory stage of the menstrual cycle.

32 hnicity, and timing of blood draw within the menstrual cycle.

33 to emotional stimuli is modulated across the menstrual cycle.

34 ed NK cell numbers in endometrium during the menstrual cycle.

35 ations were measured once in days 2-7 of the menstrual cycle.

36 nd couples' knowledge of fertile days of the menstrual cycle.

37 ges of vaginal virus loads (VVLs) during the menstrual cycle.

38 levels of physical activity can lengthen the menstrual cycle.

39 erences in activity at various stages of the menstrual cycle.

40 II and oestradiol levels observed during the menstrual cycle.

41 nduced torsades de pointes varies during the menstrual cycle.

42 ing the follicular and luteal phases of each menstrual cycle.

43 from three specimens spaced throughout each menstrual cycle.

44 ding and 13 bleeding events unrelated to the menstrual cycle.

45 endometrial methylome changes throughout the menstrual cycle.

46 he progesterone-dominant luteal phase of the menstrual cycle.

47 tenuated by hormonal fluctuations within the menstrual cycle.

48 cular (EF) and mid-luteal (ML) phases of the menstrual cycle.

49 ions in orthostatic tolerance throughout the menstrual cycle.

50 erwent imaging weekly, four times during one menstrual cycle.

51 enital than plasma concentrations across the menstrual cycle.

52 to oocytes or matured follicles in a single menstrual cycle.

53 e expressed in all tissues during the entire menstrual cycle.

54 trols, matched with respect to age, sex, and menstrual cycle.

55 western New York State, were followed for 2 menstrual cycles.

56 ar, ovulatory and mid-luteal phases of their menstrual cycles.

57 s simplex virus type 2 coinfection, during 2 menstrual cycles.

58 from the western New York region for up to 2 menstrual cycles.

59 ound in a cohort of 422 controls with normal menstrual cycles.

60 y women aged 18-44 y were followed for </= 2 menstrual cycles.

61 lowed 259 healthy women for up to 2 complete menstrual cycles.

62 ere between 18 and 40 years old with regular menstrual cycles.

63 est and reference tampons in two consecutive menstrual cycles.

64 normal menstrual cycles through two stressed menstrual cycles.

65 ferences in estrogen exposures or numbers of menstrual cycles.

66 A total of 221 participants contributed 706 menstrual cycles.

67 for 6 months or more were followed for three menstrual cycles.

68 he luteal phases of both the first and third menstrual cycles.

69 These persist between menstrual cycles.

70 matase inhibitors on the dynamics of women's menstrual cycles.

71 olled, cross-over trials, each lasting three menstrual cycles.

72 ued until the first few days of menses for 6 menstrual cycles.

73 reased by about 2.5% for every additional 10 menstrual-cycles.

74 2 expression, which persisted independent of menstrual cycling.

75 Over one menstrual cycle, 20 human immunodeficiency virus (HIV)-i

76 from Western New York were followed for </=2 menstrual cycles (2005-2007) and provided fasting blood

77 Menstrual cycle activity is the most important risk fact

78 mammography performance according to week of menstrual cycle, adjusting for age and registry.

79 To determine whether the menstrual cycle affects human immunodeficiency virus (HI

80 We conclude that the menstrual cycle affects sympathetic neural responses but

81 d during the early follicular phase of their menstrual cycles after ovulatory cycles.

82 (mean age 30+/-4 years, P=0.25) with regular menstrual cycles after validation of the technique.

83 erm contraceptive in the luteal phase of the menstrual cycle also had a 3.25 times higher frequency o

84 hypothesis that hormonal fluctuations of the menstrual cycle alter sympathetic neural activity and or

85 Menstrual cycle alterations and clinically significant o

86 of 8 women studied during two phases of the menstrual cycle and 3 women studied during their midfoll

87 HE1 during the follicular phase of the first menstrual cycle and during the luteal phases of both the

88 Hormonal changes across the menstrual cycle and during the postpartum and perimenopa

89 tion between hormone fluctuations during the menstrual cycle and human immunodeficiency virus type 1

90 y symptoms with hormonal changes through the menstrual cycle and imply a potential for individualized

91 to those observed in the luteal phase of the menstrual cycle and modestly increased in the third trim

92 Phase of the current menstrual cycle and OC use were significant determinants

93 a diversity and inflammation (controlled for menstrual cycle and other confounders).

94 ion of hormonal signalling as a phenocopy of menstrual cycle and pregnancy-like endocrine loops and h

95 female volunteers at different stages of the menstrual cycle and pregnant women were assayed.

96 ory symptoms varied significantly during the menstrual cycle and were most frequent from the midlutea

97 Irregular menstrual cycles and earlier age at menarche increased t

98 cept study that leptin can restore ovulatory menstrual cycles and improve reproductive, thyroid, and

99 st-morning urine specimens during one to two menstrual cycles and male partners collected specimens d

100 gh it is well established that the number of menstrual cycles and pregnancy (in this case transiently

101 articipants (n = 259) were followed for </=2 menstrual cycles and provided fasting blood specimens </

102 WE are more likely to experience anovulatory menstrual cycles and the effects of epilepsy syndrome, a

103 of breast-feeding, use of OCs, and irregular menstrual cycles and the multivariate-adjusted risk of R

104 the markers are measures based on successive menstrual cycles and the subsequent event is the final m

105 of the estrus cycle (equivalent to the human menstrual cycle) and of circulating levels of estradiol

106 recent partners, prior miscarriage, smoking, menstrual cycle, and douching were positively associated

107 nguished by age at onset, variability of the menstrual cycle, and duration of the early transition.

108 s to explain the LH surge in both the normal menstrual cycle, and in the treatment of Kallmann's synd

109 were detected during the luteal phase of the menstrual cycle, and longitudinal analysis showed the fr

110 After adjustment for age, phase of menstrual cycle, and presence of known cervical pathogen

111 because these hormones fluctuate across the menstrual cycle, and these fluctuations can complicate c

112 in cervical secretions is influenced by the menstrual cycle, and they suggest that the risk of heter

113 n the periovulatory and luteal phases of the menstrual cycle, and to assess the role of androgens.

114 atients up to 53 y old, predominantly at mid menstrual cycle, and were best coregistered to the fallo

115 ics and hormonal changes associated with the menstrual cycle are possible explanations for variable i

116 performance in such environments across the menstrual cycle are sparse, with mixed findings.

117 cesses, such as cell cycle, circadian clock, menstrual cycles, are governed by oscillatory systems co

118 Menstrual cycle-based menopausal status was defined for

119 No or irregular maternal menstrual cycles before pregnancy were associated with h

120 s (mean age 24.3 +/- 4.9 years) with regular menstrual cycles between 23 and 35 days.

121 lls from women in the ovulatory phase of the menstrual cycle but not from men and identify a function

122 vel was associated with a lengthening of the menstrual cycle by 0.93 days (95% confidence interval (C

123 e HPV prevalence preceded the beginning of a menstrual cycle by 9-12 days.

124 om the follicular to the luteal phase of the menstrual cycle by blocking the conversion of progestero

125 Menopause is the time of life when menstrual cycles cease, and is caused by reduced secreti

126 DTI parameters are not sensitive to menstrual cycle changes, while menopause, long-term HRT,

127 w additional questions, information on usual menstrual cycle characteristics can be collected and use

128 amined the associations of risk factors with menstrual cycle characteristics for 309 working women ag

129 immutable host factors, are associated with menstrual cycle characteristics that may in turn be rela

130 hysical activity and prospectively collected menstrual cycle characteristics were examined in two lar

131 ssociation between TCDD exposure and current menstrual cycle characteristics.

132 (P=0.0078) lower in the luteal phase of the menstrual cycle compared to the follicular phase.

133 ed to target and moderate the effects of the menstrual cycle compared with the effect of simple energ

134 men included in this review are pain and the menstrual cycle, contraception, and preconception counse

135 ype evident in vivo during the course of the menstrual cycle corresponding to fluctuating estradiol l

136 s, rather than females, were studied so that menstrual cycles could not account for differences betwe

137 es rarely account for the repeated nature of menstrual cycle data.

138 We assessed endometrial thickness for each menstrual cycle day (as an index of hormone regulation)

139 The menstrual cycle-dependent expression of melanoma antigen

140 The menstrual cycle did not alter resting MSNA (EF, 13 +/- 3

141 lts suggest that hormonal changes during the menstrual cycle do not have a significant effect on HIV-

142 dings of the present study indicate that the menstrual cycle does not affect muscle sympathetic nerve

143 These results suggest that the menstrual cycle does not affect sympathetic neural activ

144 based therapies and should be tracked in the menstrual cycle during the course of PTSD treatment.

145 r (PMDD) when given daily or for half of the menstrual cycle during the luteal phase.

146 en concentrations fluctuate over the estrous/menstrual cycle, dynamically modulating estrogen recepto

147 ption, reproductive hormones, and markers of menstrual cycle dysfunction including sporadic anovulati

148 studied: women at 2 different phases of the menstrual cycle (early follicular [early cycle] and late

149 were randomized to receive, for the next two menstrual cycles, either double-blind placebo or dutaste

150 resses genital virus shedding throughout the menstrual cycle, even in the presence of factors reporte

151 s in the follicular and luteal phases of the menstrual cycle (FDR-adjusted p-value <0.05).

152 l trigger of fluctuating sex hormones of the menstrual cycle, few studies have been done to confirm o

153 -nAChR availability were observed across the menstrual cycle for any outcome measure.

154 rovided prospectively recorded data on their menstrual cycles for many years.

155 d with placebo plus folic acid for up to six menstrual cycles; for women who conceived, study treatme

156 iated with reduced testosterone and improved menstrual cycle function in healthy premenopausal women.

157 e associations between caffeine exposure and menstrual cycle function, and we are aware of no previou

158 appear to have adverse short-term effects on menstrual cycle function, including sporadic anovulation

159 ssess RR of cycle-average alcohol intake and menstrual cycle function.

160 own between cycle-average alcohol intake and menstrual cycle function.

161 Changes in menstrual cycle functioning associated with PCBs and DDE

162 en during increasing BP (i.e. phase IV); the menstrual cycle had no influences on cardiovagal baroref

163 human papillomavirus (HPV) DNA detection and menstrual cycle has been inconsistent.

164 DSM-IV and timing of their expression in the menstrual cycle have had little empirical support.

165 varian follicles to produce the human 28-day menstrual cycle hormone profile, which controls human fe

166 e scanned twice based on normal variation in menstrual cycle hormones [i.e., early follicular (EF) co

167 ariations in respiratory symptoms during the menstrual cycle in a general population, and potential m

168 s, we hypothesized that BRCA1 influences the menstrual cycle in a way that mimics the factors underly

169 nd lesions vary according to the week of the menstrual cycle in benign but not in malignant lesions.

170 HSV entry receptor expression throughout the menstrual cycle in genital tissues was performed, and th

171 n GABA concentrations, fluctuates across the menstrual cycle in healthy women and those with premenst

172 Cortical GABA levels declined across the menstrual cycle in healthy women, whereas women with PMD

173 als, SHIV infections occurred earlier in the menstrual cycle in STI-positive macaques (P = .01, by th

174 progesterone titres during these days of the menstrual cycle in the same groups.

175 tivity did not vary significantly by week in menstrual cycle in women who had undergone mammography m

176 underlying blood pressure control across the menstrual cycle in women with POTS are unknown.

177 mptoms of orthostatic intolerance across the menstrual cycle in women with POTS.

178 mptoms of orthostatic intolerance across the menstrual cycle in women with POTS.

179 different during the EF and ML phases of the menstrual cycle in young, healthy females.

180 During 33 menstrual cycles in 25 women, HIV-1 RNA levels in vagina

181 (EBT) (n = 13) had a lower body mass, fewer menstrual cycles in the past year, lower estradiol and 2

182 Hormonal fluctuations during the menstrual cycle influence energy intake and expenditure

183 Regulation of the human menstrual cycle is a frequency dependent process control

184 Regeneration of the endometrium in each menstrual cycle is required for reproduction.

185 Food intake fluctuates throughout the menstrual cycle; it is greater during the early follicul

186 the explosion, TCDD was not associated with menstrual cycle length (adjusted beta = -0.03 days, 95%

187 5% confidence interval (CI): 0.87, 0.97) and menstrual cycle length (for >/=30 days vs. <30 days, OR

188 ve risk (RR) of type 2 DM among women with a menstrual cycle length that was 40 days or more or was t

189 They also reported their usual menstrual cycle length when not using oral contraceptive

190 [4.00] years and 13 women with no change in menstrual cycle length with a mean [SD] age of 44.92 [2.

191 41] years; including 14 women with change in menstrual cycle length with a mean [SD] age of 45.50 [4.

192 for perimenopause, which is mainly based on menstrual cycle length, was not associated with MAO-A VT

193 here are many studies based on self-reported menstrual cycle length, yet little is known about the va

194 interview with: (1) 7-day or more change in menstrual cycle length; (2) a change in menstrual flow a

195 18-44 years (mean, 27.4) with self-reported menstrual cycle lengths of 21-35 days were recruited in

196 ncy virus (SHIV) susceptibilities during the menstrual cycle, likely caused by cyclic variations in i

197 tion as against single ovulation in a normal menstrual cycle makes the procedure dependent on several

198 We used menstrual cycle markers to determine inception of perime

199 ravings and metabolic changes throughout the menstrual cycle may increase weight loss above that achi

200 onadal hormones, especially estrogen, in the menstrual cycle may play a critical role in fear extinct

201 teroid levels during the luteal phase of the menstrual cycle may precipitate affective symptoms.

202 Because intercourse patterns in the menstrual cycles may vary substantially among groups, it

203 hat was tailored to metabolic changes of the menstrual cycle (Menstralean) or to undergo simple energ

204 men were scanned at 2 discrete phases of the menstrual cycle (midcycle and late luteal).

205 oids involved in the regulation of the human menstrual cycle modulate gamma-aminobutyric acid (GABA)

206 fluctuate during puberty, pregnancy, and the menstrual cycle, more information about the hormonal mod

207 tate were followed prospectively for up to 2 menstrual cycles (n = 259) during 2005-2007.

208 York were followed prospectively for up to 2 menstrual cycles (n = 259).

209 omen, one in two of such women believe their menstrual cycle negatively impacts training and performa

210 eveloped to model hormonal regulation of the menstrual cycle of a woman from age 20 to 51.

211 estrus but not in the diestrus stage of the menstrual cycle of females was inhibited by pioglitazone

212 After one menstrual cycle of single-blind placebo, participants we

213 e (RR = 1.93, 95% CI: 0.9, 4.0 for >900 mg), menstrual cycles of use (RR = 2.16, 95% CI: 0.9, 5.2 for

214 ilability of daily hormone values for entire menstrual cycles offers an opportunity to apply new anal

215 remains controversial, and the effect of the menstrual cycle on MSNA responses to mental stress is un

216 The influence of the menstrual cycle on resting muscle sympathetic nerve acti

217 he impact of hormonal fluctuation during the menstrual cycle on the course of bipolar disorder is poo

218 sult from "allowing participants to fill out menstrual-cycle-onset calendars"

219 esult from allowing participants to fill out menstrual-cycle-onset calendars, including recall biases

220 cted urine samples during 1997-1999 from one menstrual cycle or up to 50 days from 848 women who live

221 s was stronger among women with >30 years of menstrual cycles (OR 0.66; 95% CI 0.51-0.85) than those

222 -0.85) than those with a shorter duration of menstrual cycles (OR 0.97; 95% CI 0.73-1.27), and the te

223 e not significantly affected by phase of the menstrual cycle, oral contraceptive use, or early pregna

224 ture chances of pregnancy from the number of menstrual cycles over which they have been trying to con

225 2); this sensitivity was not affected by the menstrual cycle (P = 0.747).

226 Three patients had an ovulatory menstrual cycle (P<0.05 for the comparison with an expec

227 h a shorter time since the onset of the last menstrual cycle, (P=.031, Wilcoxon rank-sum test).

228 tions with menopausal status based either on menstrual cycle patterns or on elevated (>20 IU/liter) f

229 men in the low oestrogen (E(2)) phase of the menstrual cycle, PE evoked a decrease in cRCF (30-40%; P

230 age 18-50 years; 115 male and 45 female) and menstrual cycle phase (29 follicular and 16 luteal) effe

231 on of sleep and waking while controlling for menstrual cycle phase and hormonal contraceptive use.

232 e group, prospective, observational trial of menstrual cycle phase and outcome after breast cancer su

233 ed Cl- secretion in women with CF during the menstrual cycle phase at which 17beta-estradiol level is

234 Cl(-) secretion in women with CF during the menstrual cycle phase at which 17beta-estradiol level is

235 re scanned twice during the early follicular menstrual cycle phase compared with late follicular/midc

236 Menstrual cycle phase does not appear to affect exercise

237 BAergic system is substantially modulated by menstrual cycle phase in healthy women and those with PM

238 ed for standardization of CRP measurement to menstrual cycle phase in reproductive-aged women.

239 The data also demonstrate that menstrual cycle phase is an important consideration in f

240 study investigated the influence of sex and menstrual cycle phase on the recall of fear extinction.

241 cal confirmation of overnight abstinence and menstrual cycle phase, analyses were performed to compar

242 with genital antiretroviral concentrations, menstrual cycle phase, bacterial vaginosis, genital blee

243 se in well-trained women are not affected by menstrual cycle phase, but differ between dry and humid

244 NF level was not independently influenced by menstrual cycle phase, oral contraceptive use, or plasma

245 nstrual dysphoric disorder (PMDD) and that a menstrual cycle phase-dependent abnormality in brain GAB

246 response circuitry were dependent on women's menstrual cycle phase.

247 tervention for breast cancer on the basis of menstrual cycle phase.

248 rrelated with estradiol level, regardless of menstrual cycle phase.

249 l linguistic stimuli varies depending on the menstrual cycle phase.

250 follicular (V-FP(imm)) or luteal (V-LP(imm)) menstrual cycle phase.

251 Planning study visits during specific menstrual cycle phases is important if the exposure or o

252 When menstrual cycle phases were strictly defined, neither DF

253 essions occurring during hormonally distinct menstrual cycle phases.

254 t and temporally to the estrous phase of the menstrual cycle, potentially decreasing the risk of mate

255 d as resumed by the occurrence of at least 1 menstrual cycle), pregnancies, and disease-free survival

256 s of occipital cortex GABA levels across the menstrual cycle (primary outcome measure) and had blood

257 ar menstrual cycle, undergoing treatment for menstrual cycle regularity shortly after menarche, havin

258 anscranial magnetic stimulation to determine menstrual cycle-related changes in cortical excitability

259 regnancy, typically defined as the number of menstrual cycles required to achieve a clinical pregnanc

260 Menstrual cycle-specific estimates of urinary BPA and ph

261 In a non-stressed menstrual cycle, SS animals have lower levels of estroge

262 Menstrual cycle status was based on the last menstrual p

263 Hormone parameters, menstrual cycle, symptoms of hypogonadism, and offspring

264 and progesterone levels at times during the menstrual cycle that are critical for ovulation and earl

265 the BioCycle Study were followed for up to 2 menstrual cycles; they provided fasting blood specimens

266 ly stress-resilient (HSR) and exhibit normal menstrual cycles through two stressed menstrual cycles.

267 trial cancer, we created the total number of menstrual cycles (TNMC) that a woman experienced during

268 rointestinal system, adjusts itself with the menstrual cycle to control the passage of sperm, and shi

269 between thyroid cancer and having irregular menstrual cycle, undergoing treatment for menstrual cycl

270 of demographic characteristics, phase of the menstrual cycle, use of hormonal contraceptives, and con

271 Normal menstrual cycle variations in cortical excitability are

272 he mutations adjusted for age and day of the menstrual cycle was higher (odds ratio [OR] 1.11, 95% CI

273 Regular menstrual cycle was reported by more than 90% of female

274 he endogenous fluctuation in E(2) during the menstrual cycle, we conducted a within-person repeated-m

275 he proliferative and secretory stages of the menstrual cycle were equally effective in killing Staphy

276 reports and daily symptom ratings during one menstrual cycle were examined in 70 depressed perimenopa

277 Significant rhythmic variations over the menstrual cycle were found in each symptom for all subje

278 in premenopausal women according to week of menstrual cycle were studied by using prospectively coll

279 r, periovulatory, and luteal phases of their menstrual cycle were studied.

280 Genital secretions and tissues during the menstrual cycle were studied.

281 Six healthy women with regular menstrual cycles were administered the NKB antagonist AZ

282 Very irregular menstrual cycles were associated with an increased risk

283 Female individuals with epilepsy and regular menstrual cycles were eligible for this prospective stud

284 Healthy women with normal menstrual cycles were randomly assigned to use either a

285 More than 500 menstrual cycles were studied totaling over 8,000 days.

286 rea and were 20-40 years of age, had regular menstrual cycles, were not taking oral contraceptives, a

287 were stratified according to the week of the menstrual cycle when MR imaging was performed.

288 the Hgb receptor during early phases of the menstrual cycle, when Hgb is readily available from mens

289 This could be the case during the menstrual cycle, when using hormone-based birth control,

290 breast DTI is not restricted throughout the menstrual cycle, whereas the modulations in diffusion pa

291 he epithelium of human vagina throughout the menstrual cycle, whereas the mouse vaginal epithelium ex

292 the use of oral contraceptives and return of menstrual cycle, which is subject to further investigati

293 Women with regular menstrual cycles who presented to a participating family

294 eatability, remaining almost equal along the menstrual cycle, with a low mean within-subject coeffici

295 V/SHIV has been recently associated with the menstrual cycle, with particular susceptibility observed

296 s relatively stable during this stage of the menstrual cycle, with small-scale changes affecting 5% o

297 y premenopausal women were followed for </=2 menstrual cycles, with biomarkers of lipid peroxidation

298 and had 1 year of normal weight and regular menstrual cycles, without binge eating or purging.

299 ggest that for about one week of a four-week menstrual cycle, women with CF will have a reduced abili

300 cise performance is not different across the menstrual cycle, yet is lower in humid heat, in conjunct